Last reviewed · How we verify
NCT05350878
Implementing Mobile Technology for Unhealthy Alcohol Use
NA trial testing Implementation Intervention in Alcohol Drinking in 344 participants. Completed in 1 December 2024.
1 December 2024
Quick facts
| Lead sponsor | UConn Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 344 |
| Start date | 1 October 2023 |
| Primary completion | 1 December 2024 |
| Estimated completion | 1 December 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Implementation Intervention
Conditions studied
- Alcohol Drinking — all drugs for Alcohol Drinking →
Sponsor
UConn Health — full company profile →
Who can join
18 and older, any sex, with Alcohol Drinking. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Scalable approaches are needed to support patients identified in the emergency department as unhealthy alcohol users and text messaging intervention approaches are a promising solution. However, the process of providers making text messing interventions for unhealthy alcohol use available to patients in an efficient way within already busy and overburdened emergency department workflows (i.e., implementation in real-world emergency department settings) and patients adopting them remains a new area of research. Study investigators will examine barriers and facilitators to the adoption of text messaging interventions for unhealthy alcohol use in emergency departments and use a stakeholder-engaged process to develop and test practical implementation strategies that could provide much needed support to patients who screen positive while reducing burden on emergency departments.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Implementing a text-messaging intervention for unhealthy alcohol use in emergency departments: protocol for implementation strategy development and a pilot cluster randomized implementation trial.
O'Grady MA, Kapoor S, Harrison L, Kwon N, et al · · 2022 · cited 1× · PMID 35933560 · DOI 10.1186/s43058-022-00333-y
Verify or expand the search:
- PubMed search for NCT05350878
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Implementation Intervention
Trials testing the same drug.
- NCT06689007 — FES Implementation Pediatrics · NA · completed
- NCT04796961 — Promoting Evidenced-Based Tobacco Smoking Cessation Treatment in Community Mental Health Clinics · NA · completed
Other recruiting trials for Alcohol Drinking
Currently open trials in the same condition.
- NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N · NA · recruiting
- NCT06815237 — Effects of Ketone Supplement and Alcohol on Brain Metabolism · Phase 2, PHASE3 · recruiting
- NCT06994962 — Multi-Component Breath Alcohol Intervention Phase 3 · NA · recruiting
- NCT05363878 — Development of a Culturally Grounded, Trauma-Informed Alcohol Intervention With a Reserve-Dwelling First Nation Group · NA · recruiting
- NCT06309134 — The Healthy Families Bright Futures Program · NA · recruiting
Other UConn Health trials
Trials by the same sponsor.
- NCT06115252 — Partnering to Enhance Emerging Adults' Response to Programs · NA · recruiting
- NCT04598074 — Opioid Package Prototype (OPP) · NA · not yet recruiting
- NCT06846853 — Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging) · Phase 4 · recruiting
- NCT06731764 — Novel Approaches to the Treatment of Hypothyroidism · Phase 2, PHASE3 · recruiting
- NCT06668194 — Effect of Force Magnitude on Canine Retraction and Gingival Crevicular Fluid Proteome · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05350878 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by UConn Health
- Last refreshed: 5 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05350878.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing